Ranolazine and Microvascular Angina by PET in the Emergency Department (RAMP-ED)
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
Price : $35 *
At a glance
- Drugs Ranolazine (Primary)
- Indications Syndrome X
- Focus Therapeutic Use
- Acronyms RAMP-ED
- 09 Jan 2017 Primary endpoint (Coronary Flow Reserve) has not been met,according to the results published in the clinical therapeutics.
- 09 Jan 2017 Results published in the Clinical Therapeutics.
- 09 Jun 2016 Status changed from recruiting to completed.